Following extensive discussions between industry stakeholders and state institutions, several crucial solutions have been identified to address the problems of drug availability and monitoring control. The primary aim is to ensure wider and faster access to medicinal products for patients in Latvia.

Digitization is affecting many sectors and healthcare is no exception. It is a key tool for speeding up and streamlining processes that can significantly improve the quality and availability of medical care. In the Czech Republic, the overall level of digitization in healthcare is still low.

It is not new that originator pharmaceutical companies try to block generic competitors from entering the market. Considering the recent developments in the Court of Justice of the European Union (CJEU), originators should tread carefully when defending their patents. Having a strong patent is crucial, and the consequences of failing to vet the strength of a patent could end up costly.

Healthcare is a fundamental component of any society, reflecting its core values and priorities. In Lithuania, the healthcare system is marked by a pronounced division between private and public hospitals. Lithuania’s healthcare services are divided into outpatient (ambulatory) and inpatient (stationary) services.

For the pharmaceutical industry in the Hungarian market, the first half of 2024 involved several legislative changes with significant practical implications. Some of these changes have yet to unfold their full impact, due to the lack of implementing regulations and prerequisite authority actions.

Despite the ongoing full-scale invasion by the Russian Federation, the life sciences and healthcare sector in Ukraine is actively evolving to support the well-being of its population.